|Day Low/High||106.06 / 109.27|
|52 Wk Low/High||53.06 / 123.99|
Jim Cramer says it's more than just the cloud. There are some astounding moves in the broader tech sector, too.
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ("Exact" or the "Company") (Nasdaq: EXAS).
Apple CEO says fund will boost advanced manufacturing in U.S.
A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.
Aetna now offers commercial coverage of Exact Sciences' Cologuard test.
Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.
Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.
Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.
Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.
Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.
Biotech shares have gained from takeovers in that sector.
Here's a window into what institutional investors may be doing and how to profit from that.
Exact Sciences (EXAS) stock is gaining on Monday after the National Committee for Quality Assurance updated its guidelines on colorectal cancer screening tests.
Here's a look at two stocks that are trending higher and two that are ripe for short-selling.
The most recent short interest data was recently released for the 08/31/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 8.37 "days to cover" versus the median component at 6.39.
These four stocks are looking strong technically, either breaking out or approaching breakout levels.
Which stocks have had the highest gains following earnings? Bespoke Investment came up with a list of the 40 stocks that had the best performance on their earnings reaction days.
Here are four biotech and technology stocks showing strong technical momentum.
Exact Sciences (EXAS) announced today that it would be offering 8.5 million shares of common stock.
Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, Robert W.
Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate
Exact Sciences (EXAS) is climbing today after the company reports better-than-expected 2016 second quarter earnings.
Trade-Ideas LLC identified Exact (EXAS) as a post-market leader candidate
Shares of Exact Sciences (EXAS) are gaining after reports that the company may be acquired by Illumina (ILMN).
Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate
Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.